Mural Oncology plc
DelistedCIK 1971543fmd_1WYAQ5SG8FGZP70FG8RWPYBRHKManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Sep 30, 2025, 15 periods
Latest annual · FY2024
Millions- Operating income
- (138)
- Net income
- (129)
- Free cash flow
- (129)
Latest quarter · Q3 FY2025
Millions- Operating income
- (4)
- Net income
- (4)
- Free cash flow
- (18)
Mural Oncology plc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Operating income | -$138.3 million | -$196.2 million | 10-K 2025-03-11 · proof | |
| Net income | -$128.5 million | -$207.4 million | 10-K 2025-03-11 · proof | |
| Cash from operating activities | -$128.5 million | -$194.2 million | 10-K 2025-03-11 · proof | |
| Free cash flow | -$128.6 million | -$197.7 million | 10-K 2025-03-11 · proof | |
| Total assets | $169.4 million | $301.7 million | -43.9% | 10-K 2025-03-11 · proof |
| Total liabilities | $28.9 million | $37.9 million | -23.8% | 10-K 2025-03-11 · proof |
| Cash and cash equivalents | $115.5 million | $270.9 million | -57.4% | 10-K 2025-03-11 · proof |
- What was Mural Oncology plc's operating income in fiscal 2024?
- Mural Oncology plc reported operating income of -$138.3 million for fiscal 2024 (the year ended Dec 31, 2024), against -$196.2 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2025. SEC
- What was Mural Oncology plc's net income in fiscal 2024?
- Mural Oncology plc reported net income of -$128.5 million for fiscal 2024 (the year ended Dec 31, 2024), against -$207.4 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2025. SEC
- What was Mural Oncology plc's cash from operating activities in fiscal 2024?
- Mural Oncology plc reported cash from operating activities of -$128.5 million for fiscal 2024 (the year ended Dec 31, 2024), against -$194.2 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2025. SEC
- What was Mural Oncology plc's free cash flow in fiscal 2024?
- Mural Oncology plc reported free cash flow of -$128.6 million for fiscal 2024 (the year ended Dec 31, 2024), against -$197.7 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2025. SEC
- What are Mural Oncology plc's total assets?
- As of Dec 31, 2024, Mural Oncology plc reported total assets of $169.4 million, against $301.7 million a year earlier (-43.9%). Source: the 10-K filed with the SEC on Mar 11, 2025. SEC
- What are Mural Oncology plc's total liabilities?
- As of Dec 31, 2024, Mural Oncology plc reported total liabilities of $28.9 million, against $37.9 million a year earlier (-23.8%). Source: the 10-K filed with the SEC on Mar 11, 2025. SEC
- What are Mural Oncology plc's cash and cash equivalents?
- As of Dec 31, 2024, Mural Oncology plc reported cash and cash equivalents of $115.5 million, against $270.9 million a year earlier (-57.4%). Source: the 10-K filed with the SEC on Mar 11, 2025. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1971543&period_type=annual&limit=5"Information only, not investment advice.